Omics biomarkers and early diagnostics

   
Moshkovskii S.A.1

1. Institute of Biomedical Chemistry, Moscow, Russia
Section: OMICS-Technologies
DOI: 10.18097/PBMC20176305369      PubMed Id: 29080866
Year: 2017  Volume: 63  Issue: 5  Pages: 369-372
One of main goals for omics sciences, such as transcriptomics, proteomics and metabolomics, in medicine is biomarker discovery for diagnostics of common non-infectious diseases. The opinion paper discusses diagnostic parameters, which limit the use of the biomarkers, as well as a positive predictive value, and conditions providing possible application of the biomarkers for early diagnostics. Using some examples from proteomics, it is stated that omics technologies, which measure gene expression products, are more often used to discover prognostic and predictive biomarkers. These biomarkers help to classify already diagnosed patients to groups with different disease management.
Download PDF:
Reference:

Moshkovskii S.A. (2017) Biomeditsinskaya khimiya, 63(5), 369-372.
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)